Subjects with AD and Mini-Mental State Examination score 14-26 were randomized to PF-04494700 60 mg/day 6 days , then 20 mg daily ( high dose ) ; 15 mg/day 6 days , then 5 mg daily ( low dose ) ; or placebo , for 18 months .